RUNX3 and cancer: As the use of the DNA methyltransferase (DNMT) inhibitor (5-aza-2′-deoxycytidine) also promoted RUNX3 expression in several cancer cell lines, the role of DNA methylation in RUNX3 regulation cannot be omitted [48].